360
Participants
Start Date
December 6, 2024
Primary Completion Date
April 30, 2027
Study Completion Date
December 31, 2028
Buprenorphine
All patients will receive 3 pills and will be observed for 2 hours post-study medication administration with repeated COWS at approximately hours 1 and 2. All participants will be given a referral for ongoing MOUD and will be discharged with a prescription for 16 mg daily of buprenorphine daily.
RECRUITING
University of Utah Hospital, Salt Lake City
RECRUITING
San Leandro Hospital, San Leandro
RECRUITING
Highland Hospital, Oakland
RECRUITING
Maine Medical Center, Portland
RECRUITING
Cooper University Hospital, Camden
National Drug Abuse Treatment Clinical Trials Network
NETWORK
The Emmes Company, LLC
INDUSTRY
National Institute on Drug Abuse (NIDA)
NIH
Alameda Health System
OTHER
Yale University
OTHER